A new pill called Enlicitide from Merck offers hope for cholesterol management. This first-ever oral PCSK9 inhibitor demonstrated substantial LDL reductions in a recent trial. It works alongside statins to lower bad cholesterol. This development could be a breakthrough for patients needing more effective treatment options.
Related Posts
‘Justice will be served’: FBI boss Kash Patel hails Harpreet Singh’s arrest
FBI chief Kash Patel announced the arrest of Harpreet Singh in Sacramento, wanted in India for multiple terror attacks in Punjab. The FBI coordinated with […]
Savannah James’ friend reveals backstory of her confrontation with Adele
April McDaniel shared that her friendship with Adele started unexpectedly at a gym. Initially annoyed by McDaniel’s workout breaks, Adele’s straightforwardness marked their start. However, […]
Honest admission: OpenAI CEO says company ‘might screw it up’; admits risks remain
OpenAI CEO Sam Altman stated the company’s revenue exceeds $13 billion annually, despite acknowledging potential pitfalls in its rapid growth. He addressed significant AI infrastructure […]